AzTrials
AzTrials

Physical ActivityNCT05672940

Investigations of the Effects and Associated Neural Mechanisms of Different Exercise in People With Metabolic Syndrome

A study testing Aerobic plus resistance training and Stretching plus breathing training in people with Physical Activity, run by National Taiwan University Hospital at 1 site in Taiwan.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Metabolic syndrome (MetS) is a risk for many chronic diseases of middle-aged and older adults. Hence, prevention and treatment of MetS is a crucial global health issue. However, it remains unclear regarding the cognitive effects and associated neural mechanisms of exercise interventions in this population. Read more about this study

Who is it for?
Ages 45 to 80 yearsHealthy volunteers can take part
Conditions the study is for
Physical Activity
What is being tested?
Aerobic plus resistance training and Stretching plus breathing training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
1 siteTaiwan
Study dates
12 Aug 2020to 31 Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age between 45 and 80 years old
  • Literacy
  • Diagnosed with MetS based on the International Diabetes Federation (IDF) definition (Alberti et al., 2006) The IDF definition of MetS includes central obesity, determined by waist circumference at the midpoint between the lowest rib and iliac crest being ≧ 90 cm for men and ≧ 80 cm for women, plus at least two of the following conditions- (a) TG ≧ 150 mg/dl or being treated for this lipid abnormality, (b) HDL-C < 40 mg/dl in men, < 50 mg/dl in women, or being treated for this lipid abnormality, (c) systolic blood pressure (SBP) ≧ 130 mmHg, or systolic blood pressure (DBP) ≧ 85 mmHg, or being treated for diagnosed hypertension, and (d) FPG ≧ 100 mg/dl or diagnosed Type II DM).
  • Living with a sedentary lifestyle (defined as being engaged in physical activities for less than a total of 90 minutes per week) (Fletcher et al., 1996) in recent one year.

Who cannot join

  • Having any contraindications for fMRI (e.g., claustrophobia and indwelling metals or implanted devices)
  • Serious or uncontrolled cardiovascular or pulmonary conditions (e.g., unstable angina, serious cardiac arrhythmias, heart failure, hypertrophic cardiomyopathy, severe aortic or carotid stenosis, pulmonary embolus or infarction, resting SBP ≥ 180 mmHg, or resting DBP ≥ 110 mmHg)
  • Severe renal failure (Stages 4 and 5 of chronic kidney diseases (Levin et al., 2013)
  • Symptoms or histories of neurological diseases, including transient ischemic attack
  • Severe musculoskeletal disorders which would affect their mobility
  • Diagnosis of dementia, Montreal Cognitive Assessment (MoCA) (Taiwan version) < 22 (Tsai et al., 2012; Wang et al., 2013), or inability to follow instructions
Show all 9Show fewer
  • Psychiatric disorders (including depression) or Geriatric Depression Scale-short form (GDS-15) score≧8 (Sheikh \& Yesavage, 1986)
  • Having contraindications for doing exercises (e.g., resting SBP ≥ 180 mmHg, resting DBP ≥ 110 mmHg, FPG ≥ 300 mg/dL, hypoglycemia (plasma glucose ≤ 70 mg/dL) after exercises, or postural hypotension (BP drop ≥ 20 mmHg when changing postures)
  • Life expectancy less than six months due to any disease.

Trial locations and contacts

1 site in 1 country.

Pei-Fang Tang, PhD contact

02-33668128

pftang@ntu.edu.tw

Taiwan1 site, 1 recruiting
  • National Taiwan University Collage of Public Health

    Taipei, Zhongzheng, 100

    Pei-Fang Tang, PhD, 02-33668128, pftang@ntu.edu.tw

    Recruiting

Other trials in Taiwan

About this study

Official title: Investigations of the Effects and Associated Neural Mechanisms of Different Long-term Exercise Interventions on Improving Brain, Cognitive, and Physical Functions in Middle-aged and Older Adults With Metabolic Syndrome

Metabolic syndrome (MetS) is a risk for many chronic diseases of middle-aged and older adults. Hence, prevention and treatment of MetS is a crucial global health issue. However, it remains unclear regarding the cognitive effects and associated neural mechanisms of exercise interventions in this population. Therefore, the aims of this three-year project are to compare the effects and neural mechanism of three different types of exercise interventions, on components of MetS, as well as neuropsychological and physical functions in middle-aged and older adults with MetS.

Read the detailed description

This three-year study is an assessor-blind randomized controlled clinical trial. Another 67 middle-aged and older adults with MetS without regular exercise habits will be recruited and randomly assigned into the combined aerobic and resistance training (AT/RT) or Control (stretching and breathing exercise, ST/BR) group. All participants will undertake three one-hour sessions of exercises for 12 weeks, being supervised . Participants will also wear a wearable device that monitors, records, and provides feedback about their physical activity levels and heart rates during the entire 12 weeks. The outcome measures include participants's components of MetS and performance on neuropsychological and physical tests and structural and functional brain imaging parameters collected at pre-training, and post-training (week 12) tests. The investigators will compare the differences on all of these outcome measures and analyze the relationships between changes in brain structure and functional activation in relationship with other outcome measures in order to understand the neural mechanisms of the training effects and the differences in these mechanisms between the two groups.

Results of this study will provide important scientific evidence and clinical decision bases for determining effective exercise interventions in preventing the progression of MetS, improving neuropsychological and physical functions of MetS, as well as elucidating the neural mechanisms underlying these improvements.

Being tested
Aerobic plus resistance training, Stretching plus breathing training
Keywords
Neuroimage, Training, Aging, Brain, Cardiovascular risks, Metabolic syndrome
Medical subject headings
Motor Activity, Metabolic Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Aerobic plus resistance trainingBehavioural

    Aerobic plus resistance training

  • Stretching plus breathing trainingBehavioural

    Stretching plus breathing training

Study groups in NCT05672940
Study groupRoleWhat they receive
Aerobic plus resistance training groupExperimentalReceive three one-hour supervised group sessions weekly for 12 weeks, in which Sections 1 and 3 were AT plus RT sessions, including 5-minute warm-up, 30-minute AT exercises on a bicycle (Comfort 408, Horizon Fitness) or a treadmill (832T, Horizon Fitness), 20-minute RT, and 5-minute cool-down; whereas Section 2 was an AT-only session, including 5-minute warm up, 50-minute aerobic exercises (bicycling or treadmill walking), and 5-minute cool-down.
Receives: Behavioral: Aerobic plus resistance training
Stretching plus breathing training groupExperimentalReceive three one-hour sessions of weekly supervised group training combining Tongtze Gymnastics (童子體操) and breathing exercises for 12 weeks.
Receives: Behavioral: Stretching plus breathing training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes of brain functional activation and structure imaging

    Functional Magnetic Resonance Imaging (fMRI) activation patterns and white and gray matter changes of the brain

    Measured: at baseline, 12 weeks exercise intervention

Secondary outcomes (15)
  1. Neuropsychological test-CANTAB

    Cambridge Neuropsychological Test Automated Battery

    Measured: at baseline, 12 weeks exercise intervention

  2. Neuropsychological test-AD8

    Ascertain Dementia-8

    Measured: at baseline, 12 weeks exercise intervention

  3. Neuropsychological test-MoCA

    Montreal Cognitive Assessment-Taiwan version

    Measured: at baseline, 12 weeks exercise intervention

  4. Neuropsychological test-CDR

    Clinical Dementia Rating

    Measured: at baseline, 12 weeks exercise intervention

  5. Neuropsychological test-CTT

    Color Trail Test (in seconds)

    Measured: at baseline, 12 weeks exercise intervention

  6. Physical test-Muscle strength

    Bilateral grip strength and knee extensor strength (in kilograms)

    Measured: at baseline, 12 weeks exercise intervention

  7. Physical test-Flexibility

    Chair Sit and Reach Test, The upper extremity and lower extremity/trunk flexibility were measured with the Scratch Test (in centimeters)

    Measured: at baseline, 12 weeks exercise intervention

  8. Physical test-Balance and mobility

    One-legged Standing (in seconds)

    Measured: at baseline, 12 weeks exercise intervention

  9. Physical test-Balance and mobility

    Chair Rise Test (in seconds)

    Measured: at baseline, 12 weeks exercise intervention

  10. Physical test-Balance and mobility

    Four Square Step Test (in seconds)

    Measured: at baseline, 12 weeks exercise intervention

  11. Physical test-Gait mat

    Gait analysis

    Measured: at baseline, 12 weeks exercise intervention

  12. Physical test-Heart rate variability

    Heart rate variability

    Measured: at baseline, 12 weeks exercise intervention

  13. Physical test-Cardiovascular fitness

    Cardiovascular fitness: 6-minute Walk Test

    Measured: at baseline, 12 weeks exercise intervention

  14. Cardiopulmonary test

    Cycling on the cycle ergometer: Indicate participant's submaximal and maximal cardiovascular fitness level, respectively, and served as references when setting participant's target heart rate for exercise training

    Measured: at baseline, 12 weeks exercise intervention

  15. Number of participants with Abnormal Laboratory Values

    The following MetS and cardiovascular risk related biomarkers: total cholesterol, triglyceride, HDL, LDL, Fasting plasma glucose, fasting plasma insulin, HbA1c, serum adiponectin level, serum leptin level, and homocysteine

    Measured: at baseline, 12 weeks exercise intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Jan 2023
  2. Study start12 Aug 2020
  3. Primary completion31 Jul 2023 (estimated)
  4. Study completion31 Dec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05672940
Sponsor's protocol ID
201912239RINB
Other IDs
MOST 111-2314-B-002-163 -
Status last verified
Dec 2022
First submitted
19 Dec 2022
Last updated
5 Jan 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Aerobic plus resistance training and Stretching plus breathing training in people with Physical Activity, run by National Taiwan University Hospital at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 5 Jan 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Pei-Fang Tang, PhD (02-33668128, pftang@ntu.edu.tw), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes of brain functional activation and structure imaging (time frame: at baseline, 12 weeks exercise intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jan 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in